RM Califf
- Internal Medicine top 2%
- Venous Thromboembolism Diagnosis and Management 5
-
- Acute Myocardial Infarction Research 12
- Antiplatelet Therapy and Cardiovascular Diseases 8
- Atrial Fibrillation Management and Outcomes 6
- Cardiac Valve Diseases and Treatments 5
- Cardiac, Anesthesia and Surgical Outcomes 5
- Surgery top 5%
- Coronary Interventions and Diagnostics 6
-
- Cardiac Imaging and Diagnostics 8
RM Califf
38 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 93
- Internal Medicine 280
- Cardiology and Cardiovascular Medicine 1.3k
- Surgery 632
- Radiology, Nuclear Medicine and Imaging 321
- Epidemiology 170
Countries citing papers authored by RM Califf
This map shows the geographic impact of RM Califf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by RM Califf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites RM Califf more than expected).
Fields of papers citing papers by RM Califf
This network shows the impact of papers produced by RM Califf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by RM Califf. The network helps show where RM Califf may publish in the future.
Co-authorship network
The 25 scholars most cited alongside RM Califf, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 125 | |
| 2 | 2013 | 67 | |
| 3 | 2008 | 27 | |
| 4 | 2007 | 205 | |
| 5 | 2007 | 7 | |
| 6 | Higher Aspirin Dose is Associated with Reduced Mortality and More Serious Bleeding in Patients with Recent Cerebrovascular or Coronary Ischemic Events: Insights from the BRAVO Trial | 2003 | 1 |
| 7 | Optimal dosing of a glycoprotein IIb/IIIa antagonist with simplified renal-based algorithm: pharmacodynamic and clinical findings from PARAGON B | 2001 | 0 |
| 8 | Diabetes doubles the risk of death among patients presenting with acute coronary syndromes: insights from SYMPHONY, a large international trial | 2001 | 1 |
| 9 | Higher aPTTs associated with worse outcomes after thrombolytic therapy with reduced-dose heparin: results from Assent-2 | 2000 | 2 |
| 10 | Delaying and Preventing Ischemic Events in Patients with Acute Coronary Syndromes Using the Platelet Glycoprotein IIb/IIIa Inhibitor Lamifiban | 1997 | 8 |
| 11 | Amplification of clinical benefit at six months with the glycoprotein IIb/IIIa inhibitor lamifiban in patients with non ST segment elevation in acute coronary syndromes | 1997 | 4 |
| 12 | 1995 | 4 | |
| 13 | 1995 | 21 | |
| 14 | One year followup from the GUSTO I trial | 1994 | 5 |
| 15 | Determinants of early versus late cardiac death in patients undergoing coronary artery bypass graft surgery. | 1991 | 122 |
| 16 | Resource use and cost of initial coronary revascularization. Coronary angioplasty versus coronary bypass surgery. | 1990 | 66 |
| 17 | 1990 | 2 | |
| 18 | 1988 | 65 | |
| 19 | Clinical Databases: Accomplishments and Unrealized Potential | 1985 | 13 |
| 20 | 1984 | 5 |
About RM Califf
RM Califf is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine, Surgery, Radiology, Nuclear Medicine and Imaging and Anesthesiology and Pain Medicine, having authored 40 papers that have together received 1.6k indexed citations. Recurring topics across this work include Acute Myocardial Infarction Research (12 papers), Antiplatelet Therapy and Cardiovascular Diseases (8 papers), Cardiac Imaging and Diagnostics (8 papers), Atrial Fibrillation Management and Outcomes (6 papers), Coronary Interventions and Diagnostics (6 papers), Cardiac Valve Diseases and Treatments (5 papers), Cardiac, Anesthesia and Surgical Outcomes (5 papers) and Venous Thromboembolism Diagnosis and Management (5 papers). The work is most often cited by research in Internal Medicine (280 citations), Cardiology and Cardiovascular Medicine (1.3k citations), Surgery (632 citations), Radiology, Nuclear Medicine and Imaging (321 citations) and Epidemiology (170 citations). RM Califf has collaborated with scholars based in United States, Canada and Australia. Frequent co-authors include Pryor Db, KL Lee, Harrell Fe, Christopher B. Granger, Mark A. Hlatky, Rankin Js, Sunil V. Rao, John W. Eikelboom, Robert A. Harrington and Jean‐Pierre Bassand. Their work appears in journals such as Circulation, European Heart Journal, Journal of the American College of Cardiology, American Journal of Roentgenology and Clinical Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.